Currently, Nyloxin is available as an oral spray in US for joint pain, back pain, neck aches, migraines, headaches and neuralgia and as atopical gel to treat arthritis pain, neck pain, jaoint pain and pain from repetitive stress.
The company said the registration process for Cobroxin and Nyloxin is under progress in more than 20 countries.
Nutra Pharma chairman and CEO Rik Deitsch said MedicinesConsult has already begun the registration process for Nyloxin products in Jordan and will begin marketing campaign throughout the Middle East once they have regulatory clearance.